Gurpreet Sandhu Singh

Gurpreet Sandhu Singh

Active Director Director DIN 02685996
DIN 02685996 First appointment Oct 2009 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 6 active board seats
Past companies 7 historical roles
Total affiliations 13 Since Oct 2009
Shareholding value •••• Premium profile

About Gurpreet Sandhu Singh

Data last updated:

Gurpreet Sandhu Singh is a Director at Akira Pharma Private Limited (since 2009), Director at Careindia Health Private Limited (since 2016) and Director at Reva Medicare Private Limited (since 2016), and holds 3 more current directorships. The companies operate in Pharma, Healthcare and Real Estate and Construction. The 6 current companies with reported revenue have a combined latest revenue of ₹11.26 Cr; the largest is Akira Pharma Private Limited at ₹6.66 Cr (FY 2025). Earlier, Gurpreet Sandhu Singh was a Whole-Time Director at Akums Lifesciences Limited (2010–2013) and Individual Promoter at Revapharma Private Limited (2019–2020) and 5 more.

DIN 02685996
Primary Designation Director
Industry Pharma
First Appointment 06 Oct 2009
Oldest Company Age 17 yrs
Largest company Akira Pharma Private Limited · ₹6.66 Cr (FY 2025)
Combined revenue ₹11.26 Cr across 6 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Akira Pharma Private Limited U51101DL2009PTC196057
Director17 Nov 20092009₹6.66 Cr (FY 2025)Active
Careindia Health Private Limited U74999PB2016PTC045539
Director22 Jul 20162016₹1.62 Cr (FY 2025)Active
Reva Medicare Private Limited U24248KA2016PTC086047
Director12 Feb 20162016₹1.26 Cr (FY 2025)Active
Revapharma Llp AAR-9430
Designated Partner17 Feb 20202020₹1.14 Cr (FY 2023)Active
Akira Developers Private Limited U70109DL2009PTC194942
Director06 Oct 20092009₹58.4 Lakh (FY 2025)Active
Director19 Apr 20182018₹13,829 (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Akums Lifesciences Limited U24231CH1996PLC017755
Whole-Time Director08 Nov 20101996₹223 Cr (FY 2023)Amalgamated
Revapharma Private Limited U24299DL2019PTC347678
Individual Promoter26 Mar 20192019Converted To Llp
Director17 Dec 20122012₹80.4 Lakh (FY 2025)Active
Reva Pharmachem Private Limited U24232KA2009PTC051596
Director03 Mar 20102009Strike Off
Ironmen Engineers Private Limited U28121PB2012PTC036913
Director02 Jan 20182012Strike Off
Meriwealth Homes Private Limited U74110DL2014PTC266717
Director21 Mar 20142014Strike Off
Designated Partner27 Aug 20182018Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Revapharma Llp
Reva Pharmachem Private Limited
Ironmen Engineers Private Limited
Akira Pharma Private Limited
Premium access

Shareholding and investment profile for Gurpreet Sandhu Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Gurpreet Sandhu Singh

Gurpreet Sandhu Singh currently holds 6 directorships: Akira Pharma Private Limited (Director, since 17 Nov 2009, revenue ₹6.66 Cr (FY 2025)); Careindia Health Private Limited (Director, since 22 Jul 2016, revenue ₹1.62 Cr (FY 2025)); Reva Medicare Private Limited (Director, since 12 Feb 2016, revenue ₹1.26 Cr (FY 2025)); Revapharma Llp (Designated Partner, since 17 Feb 2020, revenue ₹1.14 Cr (FY 2023)); Akira Developers Private Limited (Director, since 06 Oct 2009, revenue ₹58.4 Lakh (FY 2025)); and 1 more.

Gurpreet Sandhu Singh was first appointed on 06 Oct 2009 as Director at Akira Developers Private Limited. The most recent appointment on record is 17 Feb 2020 at Revapharma Llp.

The 6 current companies of Gurpreet Sandhu Singh that report revenue have a combined latest revenue of ₹11.26 Cr: Akira Pharma Private Limited ₹6.66 Cr (FY 2025); Careindia Health Private Limited ₹1.62 Cr (FY 2025); Reva Medicare Private Limited ₹1.26 Cr (FY 2025); Revapharma Llp ₹1.14 Cr (FY 2023); Akira Developers Private Limited ₹58.4 Lakh (FY 2025); and 1 more.

Gurpreet Sandhu Singh held 7 earlier board appointments: Akums Lifesciences Limited (Whole-Time Director, 08 Nov 2010 to 01 Feb 2013); Revapharma Private Limited (Individual Promoter, 26 Mar 2019 to 16 Feb 2020); Ca Circuit Technologies Private Limited (Director, 17 Dec 2012 to 04 Dec 2017); Reva Pharmachem Private Limited (Director, from 03 Mar 2010); Ironmen Engineers Private Limited (Director, from 02 Jan 2018); and 2 more.

The current boards of Gurpreet Sandhu Singh's companies include Trilochan Singh Sandhu (Akira Pharma Private Limited), Amritah Sandhu (Careindia Health Private Limited), Ramakant Innani (Reva Medicare Private Limited), Shishant Gupta (Revapharma Llp), Sanjeev Kumar Sethi (Council For Healthcare And Pharma Front).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available